CIK 0001404644
- Non-accelerated filer
- Smaller reporting company
Neurogene Inc.
Sign in to watch- Ticker
- NGNE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 980542593
- Phone
- +1 877-237-5020
- Business address
- 535 W 24TH STREET, 5TH FLOOR, NEW YORK, NY, 10011
- Former names
- Neoleukin Therapeutics, Inc., AQUINOX PHARMACEUTICALS, INC, AQUINOX PHARMACEUTICALS (USA) INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2014-03-12 | Bridger Gary Director | Grant or award · Common Exchangeable Shares | +36,502 | $11.00 | $402K | 40,147 |
| 2014-03-12 | Bridger Gary Director | Conversion · Common Exchangeable Shares | −40,147 | 0 | ||
| 2014-03-12 | Bridger Gary Director | Conversion · Series A-1 Exchangeable Shares | −284,090 | 0 | ||
| 2014-03-12 | Bridger Gary Director | Conversion · Series A-1 Preferred Stock | +284,090 | 0 | ||
| 2014-03-12 | Bridger Gary Director | Conversion · Series A-1 Preferred Stock | −284,090 | 0 | ||
| 2014-03-12 | Bridger Gary Director | Conversion · Series A-2 Exchangeable Shares | −189,393 | 0 | ||
| 2014-03-12 | Bridger Gary Director | Conversion · Series A-2 Preferred Stock | +189,393 | 0 | ||
| 2014-03-12 | Bridger Gary Director | Conversion · Series A-2 Preferred Stock | −189,393 | 0 | ||
| 2014-03-12 | Bridger Gary Director | Conversion · Series B-1 Exchangeable Shares | −326,538 | 0 | ||
| 2014-03-12 | Bridger Gary Director | Conversion · Series B-1 Preferred Stock | +326,538 | 0 | ||
| 2014-03-12 | Bridger Gary Director | Conversion · Series B-1 Preferred Stock | −326,538 | 0 | ||
| 2014-03-12 | Bridger Gary Director | Conversion · Series B-2 Exchangeable Shares | −325,035 | 0 | ||
| 2014-03-12 | Bridger Gary Director | Conversion · Series B-2 Preferred Stock | +325,035 | 0 | ||
| 2014-03-12 | Bridger Gary Director | Conversion · Series B-2 Preferred Stock | −325,035 | 0 | ||
| 2014-03-12 | Bridger Gary Director | Conversion · Series C Exchangeable Shares | −378,786 | 0 | ||
| 2014-03-12 | Bridger Gary Director | Conversion · Series C Preferred Stock | +378,786 | 0 | ||
| 2014-03-12 | Bridger Gary Director | Conversion · Series C Preferred Stock | −378,786 | 0 | ||
| 2014-03-12 | PFIZER INC 10% owner | Conversion | +962,603 | 962,603 | ||
| 2014-03-12 | PFIZER INC 10% owner | Purchase | +272,727 | $11.00 | $3.0M | 1,235,330 |
| 2014-03-12 | PFIZER INC 10% owner | Conversion · Series B-1 Preferred Stock | −334,420 | 0 |
Page 26 of 27 · 537 trades